226 related articles for article (PubMed ID: 31819190)
1. Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2 (PKM2).
James AD; Richardson DA; Oh IW; Sritangos P; Attard T; Barrett L; Bruce JIE
Br J Cancer; 2020 Jan; 122(2):266-278. PubMed ID: 31819190
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
[TBL] [Abstract][Full Text] [Related]
3. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
Li C; Zhao Z; Zhou Z; Liu R
Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
[TBL] [Abstract][Full Text] [Related]
4. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
[TBL] [Abstract][Full Text] [Related]
5. The Plasma Membrane Calcium Pump in Pancreatic Cancer Cells Exhibiting the Warburg Effect Relies on Glycolytic ATP.
James AD; Patel W; Butt Z; Adiamah M; Dakhel R; Latif A; Uggenti C; Swanton E; Imamura H; Siriwardena AK; Bruce JI
J Biol Chem; 2015 Oct; 290(41):24760-71. PubMed ID: 26294767
[TBL] [Abstract][Full Text] [Related]
6. Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3).
Richardson DA; Sritangos P; James AD; Sultan A; Bruce JIE
Cancer Metab; 2020; 8():2. PubMed ID: 32266066
[TBL] [Abstract][Full Text] [Related]
7. RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion.
Xu Y; Chu L; Yuan S; Yang Y; Yang Y; Xu B; Zhang K; Liu XY; Wang R; Fang L; Chen Z; Liang Z
Cell Death Dis; 2017 Jun; 8(6):e2835. PubMed ID: 28569774
[TBL] [Abstract][Full Text] [Related]
8. Glycolytic ATP fuels the plasma membrane calcium pump critical for pancreatic cancer cell survival.
James AD; Chan A; Erice O; Siriwardena AK; Bruce JI
J Biol Chem; 2013 Dec; 288(50):36007-19. PubMed ID: 24158437
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein.
Cheng TY; Yang YC; Wang HP; Tien YW; Shun CT; Huang HY; Hsiao M; Hua KT
Oncogene; 2018 Mar; 37(13):1730-1742. PubMed ID: 29335522
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development.
Jia Y; Li HY; Wang Y; Wang J; Zhu JW; Wei YY; Lou L; Chen X; Mo SJ
Int J Biol Sci; 2021; 17(11):2772-2794. PubMed ID: 34345207
[TBL] [Abstract][Full Text] [Related]
11. MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.
Yu T; Li G; Wang C; Gong G; Wang L; Li C; Chen Y; Wang X
RNA Biol; 2021 Dec; 18(12):2513-2530. PubMed ID: 34110962
[TBL] [Abstract][Full Text] [Related]
12. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C
Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354
[TBL] [Abstract][Full Text] [Related]
13. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.
Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G
Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
16. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
Martin SP; Fako V; Dang H; Dominguez DA; Khatib S; Ma L; Wang H; Zheng W; Wang XW
J Exp Clin Cancer Res; 2020 Jun; 39(1):99. PubMed ID: 32487192
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
Thonsri U; Seubwai W; Waraasawapati S; Wongkham S; Boonmars T; Cha'on U; Wongkham C
Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma.
Lockney NA; Zhang M; Lu Y; Sopha SC; Washington MK; Merchant N; Zhao Z; Shyr Y; Chakravarthy AB; Xia F
J Gastrointest Cancer; 2015 Dec; 46(4):390-8. PubMed ID: 26385349
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells.
Kim DJ; Park YS; Kang MG; You YM; Jung Y; Koo H; Kim JA; Kim MJ; Hong SM; Lee KB; Jang JJ; Park KC; Yeom YI
Exp Cell Res; 2015 Aug; 336(1):119-29. PubMed ID: 26112218
[TBL] [Abstract][Full Text] [Related]
20. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
